PALISADE BIO, INC. current report, 15 March 2016

SEC Filing Summary: Neuralstem, Inc. (Form 8-K)

Business Context and Reporting Period

This Form 8-K was filed by Neuralstem, Inc. on March 16, 2016, reporting an event that occurred on March 15, 2016. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is informational and does not contain financial statements or quantitative performance data.

Material Changes

There are no material financial changes reported in this document. The filing discloses that the Company presented at the 28th Annual Roth Conference in Dana Point, California, on March 15, 2016.

Guidance, Outlook, and Risks

Management commentary is limited to the disclosure of the conference presentation. The full content of the presentation, which may contain outlook or strategic updates, is attached as Exhibit 99.01. No specific risks, contingencies, or unusual items are detailed within the body of this 8-K.

Investor Verification Checklist

  • Review Exhibit 99.01 (Slides Presented at Conference) for specific business updates or strategic guidance.
  • Verify the date of the Roth Conference presentation (March 15, 2016) against other market communications.
  • Note that this filing contains no audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.